GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pa Shun International Holdings Ltd (HKSE:00574) » Definitions » EBITDA Margin %

Pa Shun International Holdings (HKSE:00574) EBITDA Margin % : 13.50% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Pa Shun International Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Pa Shun International Holdings's EBITDA for the six months ended in Dec. 2023 was HK$6.9 Mil. Pa Shun International Holdings's Revenue for the six months ended in Dec. 2023 was HK$51.0 Mil. Therefore, Pa Shun International Holdings's EBITDA margin for the quarter that ended in Dec. 2023 was 13.50%.


Pa Shun International Holdings EBITDA Margin % Historical Data

The historical data trend for Pa Shun International Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pa Shun International Holdings EBITDA Margin % Chart

Pa Shun International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -20.27 -85.75 -356.73 -40.39 15.18

Pa Shun International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -822.10 -1.54 -83.61 12.14 13.50

Competitive Comparison of Pa Shun International Holdings's EBITDA Margin %

For the Pharmaceutical Retailers subindustry, Pa Shun International Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pa Shun International Holdings's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pa Shun International Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Pa Shun International Holdings's EBITDA Margin % falls into.



Pa Shun International Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Pa Shun International Holdings's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=21.491/141.568
=15.18 %

Pa Shun International Holdings's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=6.879/50.968
=13.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pa Shun International Holdings  (HKSE:00574) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Pa Shun International Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Pa Shun International Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pa Shun International Holdings (HKSE:00574) Business Description

Traded in Other Exchanges
N/A
Address
229 Wufuqiao East Road, No. 608-616, Building 28, Longfor North Paradise Walk 2, Jinniu District, Sichuan Province, Chengdu, CHN
Pa Shun International Holdings Ltd is an investment holding company engaged in the manufacturing and distribution of pharmaceutical products. The business activity of the group is operated through Pharmaceutical distribution and Pharmaceutical manufacturing segment. Geographically all the activities are carried out in the PRC. The company derives the majority of revenue from the Pharmaceutical distribution segment which include sales of pharmaceutical products to wholesalers, franchise retail pharmacy chain stores and hospitals and other medical institutions in rural areas.
Executives
Zhongtai International Asset Management (singapore) Pte. Ltd. 2102 Investment manager
Arab Osman Mohammed 2104 Agent
Lai Wing Lun 2104 Agent
Win Win Stable No.3 Fund Sp 2106 Person having a security interest in shares
Zhongtai Innovation Capital Management Limited 2102 Investment manager
Chen Yenfei 2101 Beneficial owner
Praise Treasure Limited 2101 Beneficial owner

Pa Shun International Holdings (HKSE:00574) Headlines

No Headlines